Dr. Shana Kelley is an accomplished scientist and leader serving as the President of the Chan Zuckerberg Biohub Chicago. Renowned for her expertise in biochemistry, analytical chemistry, and bioengineering, Dr. Kelley has dedicated her career to advancing the development of innovative technologies in healthcare. Her research focuses on creating novel diagnostic tools, biosensors, and therapeutic platforms, with applications that enhance the detection and treatment of diseases.

Before joining CZ Biohub Chicago, Dr. Kelley held prominent academic and leadership roles, contributing significantly to scientific research and translational medicine. She is recognized for fostering interdisciplinary collaboration and pushing the boundaries of biomedical innovation. As President of CZ Biohub Chicago, she drives initiatives that integrate cutting-edge science and technology, aiming to unravel complex biological processes and revolutionize disease management.